Detalhe da pesquisa
1.
In vivo genotoxicity assessment of N-(-9 acridinyl)-b-alanine hydrochloride (S-300) using a validated Pig-a mutagenesis assay.
Transfusion
; 64(6): 1097-1108, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38716879
2.
Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storage.
Transfusion
; 62(8): 1619-1629, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35808974
3.
Preclinical safety assessment of pathogen reduced red blood cells treated with amustaline and glutathione.
Transfusion
; 60(2): 358-366, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31930533
4.
Prevalence of natural and acquired antibodies to amustaline/glutathione pathogen reduced red blood cells.
Transfusion
; 60(10): 2389-2398, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32692456
5.
Amustaline-glutathione pathogen-reduced red blood cell concentrates for transfusion-dependent thalassaemia.
Br J Haematol
; 186(4): 625-636, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31148155
6.
Red blood cells treated with the amustaline (S-303) pathogen reduction system: a transfusion study in cardiac surgery.
Transfusion
; 58(4): 905-916, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29498049
7.
Plasma treated with amotosalen and ultraviolet A light retains activity for hemostasis after 5 days post-thaw storage at 1 to 6o C.
Transfusion
; 57(4): 997-1006, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28150310
8.
Red blood cell in vitro quality and function is maintained after S-303 pathogen inactivation treatment.
Transfusion
; 54(7): 1798-807, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24617658
9.
Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study-protocol for a phase 3, randomized, controlled trial.
Trials
; 24(1): 799, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38082326
10.
Preclinical pharmacokinetic and toxicology assessment of red blood cells prepared with S-303 pathogen inactivation treatment.
Transfusion
; 51(10): 2208-18, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21985050
11.
Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process.
Transfusion
; 51(11): 2367-76, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21569044
12.
Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell Concentrates.
Transfus Med Hemother
; 38(1): 33-42, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21779204